The current use of glaucoma virtual clinics in Europe.
Journal
Eye (London, England)
ISSN: 1476-5454
Titre abrégé: Eye (Lond)
Pays: England
ID NLM: 8703986
Informations de publication
Date de publication:
05 2023
05 2023
Historique:
received:
13
11
2021
accepted:
13
05
2022
revised:
26
04
2022
medline:
11
5
2023
pubmed:
12
6
2022
entrez:
11
6
2022
Statut:
ppublish
Résumé
To assess and describe current utilisation, characteristics and perspectives on virtual glaucoma clinics (VGCs) amongst European glaucoma specialists. Cross-sectional, anonymized, online questionnaire distributed to all European Glaucoma Society-registered specialists. Questions were stratified into five domains: Demographics, Questions about VGC use, Questions for non-VGC users, COVID-19 effects, and VGC advantages/disadvantages. 30% of 169 participants currently use VGCs, with 53% based in the United Kingdom. Of those using VGCs, 85% reported higher patient acceptance compared to traditional care. The commonest virtual model was asynchronous remote monitoring (54%). Nurses (49%) and ophthalmic technicians (46%) were mostly responsible for data collection, with two-thirds using a mixture of professionals. Consultant ophthalmologists were the main decision-makers in 51% of VGCs. Preferred cohorts were: ocular hypertension (85%), glaucoma suspects (80%), early/moderate glaucoma in worse eye (68%), stable glaucoma irrespective of treatment (59%) and stable glaucoma on monotherapy (51%). Commonest investigations were: IOP (90%), BCVA (88%), visual field testing (85%) and OCT (78%), with 33 different combinations. Reasons for face-to-face referral included: visual field progression (80%), 'above-target' IOP (63%), and OCT progression (51%). Reasons for not using VGCs included: lack of experience (47%), adequate systems in place (42%), no appropriate staff (34%) and insufficient time/money (34%). 55% of non-VGC users are interested in their use with 38% currently considering future implementation. 83% stated VGC consultations have increased during the COVID-19 pandemic; 86% of all participants felt that the pandemic has highlighted the importance of VGCs. A significant proportion of European glaucoma units are currently using VGCs, while others are considering implementation. Financial reimbursement and consensus guidelines are potentially crucial steps in VGC uptake.
Identifiants
pubmed: 35690678
doi: 10.1038/s41433-022-02111-5
pii: 10.1038/s41433-022-02111-5
pmc: PMC9188015
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1350-1356Informations de copyright
© 2022. The Author(s).
Références
Br J Ophthalmol. 2003 Jun;87(6):726-30
pubmed: 12770970
Eye (Lond). 2012 May;26(5):729-33
pubmed: 22388592
Ther Adv Ophthalmol. 2020 Oct 20;12:2515841420964099
pubmed: 33283153
Br J Ophthalmol. 2006 May;90(5):579-85
pubmed: 16622087
PLoS One. 2015 Sep 18;10(9):e0137913
pubmed: 26382956
Ophthalmic Physiol Opt. 2011 Mar;31(2):168-73
pubmed: 21309803
Graefes Arch Clin Exp Ophthalmol. 2020 Dec;258(12):2655-2660
pubmed: 32960319
Ophthalmology. 2014 Nov;121(11):2081-90
pubmed: 24974815
Eye (Lond). 2014 Jul;28(7):779-83
pubmed: 25008575
Br J Ophthalmol. 2014 Dec;98(12):1605-11
pubmed: 24723617
BMJ Open. 2013 May 03;3(5):
pubmed: 23645919
Br J Ophthalmol. 1996 Jan;80(1):40-8
pubmed: 8664231
Acta Ophthalmol. 2016 Nov;94(7):730-735
pubmed: 27422769
Ophthalmic Physiol Opt. 2011 Jul;31(4):353-9
pubmed: 21535068
Br J Ophthalmol. 2017 Jul;101(7):892-895
pubmed: 27729310
Br J Ophthalmol. 2018 Apr;102(4):531-534
pubmed: 28821554
Clin Ophthalmol. 2015 Apr 24;9:745-9
pubmed: 25987832
J Telemed Telecare. 2012 Oct;18(7):367-73
pubmed: 22977196
PLoS One. 2014 Dec 05;9(12):e113779
pubmed: 25479593
Telemed J E Health. 2020 Apr;26(4):551-555
pubmed: 32209001
Br J Ophthalmol. 2021 Dec;105(12):1738-1743
pubmed: 33067360
Ophthalmology. 2007 Jan;114(1):33-9
pubmed: 17070597
J Telemed Telecare. 2004;10(6):331-6
pubmed: 15603630
Clin Ophthalmol. 2015 Oct 15;9:1915-23
pubmed: 26508830
Br J Ophthalmol. 2015 Mar;99(3):313-7
pubmed: 25336582
Ophthalmic Physiol Opt. 2000 Sep;20(5):351-9
pubmed: 11045243
Lancet Glob Health. 2021 Feb;9(2):e144-e160
pubmed: 33275949
Clin Exp Optom. 2016 Mar;99(2):163-7
pubmed: 26956453